Senti Biosciences, Inc. — All Filings
311 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001079973-25-000394 | Mar 14, 2025 | Mar 10, 2025 |
| SCHEDULE 13D | — | 0001079973-25-000383 | Mar 13, 2025 | — |
| 3 | — | 0001079973-25-000385 | Mar 13, 2025 | Mar 6, 2025 |
| 3 | 3 | 0000950170-25-038276 | Mar 12, 2025 | Mar 6, 2025 |
| 4 | 4 | 0000950170-25-038280 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | PRIMARY DOCUMENT | 0001578563-25-000173 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | FORM 4 | 0001854270-25-000029 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | FORM 4 | 0001854270-25-000030 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | FORM 4 | 0001854270-25-000031 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | FORM 4 | 0001854270-25-000032 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | FORM 4 | 0001854270-25-000034 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | FORM 4 | 0001854270-25-000028 | Mar 11, 2025 | Mar 7, 2025 |
| 3 | FORM 3 | 0001854270-25-000027 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | 4 | 0000950170-25-037187 | Mar 11, 2025 | Mar 7, 2025 |
| 4 | FORM 4 | 0001854270-25-000026 | Mar 11, 2025 | Mar 7, 2025 |
| 3 | FORM 3 | 0001854270-25-000025 | Mar 11, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001854270-25-000013 | Mar 10, 2025 | Mar 6, 2025 |
| 4 | FORM 4 | 0001854270-25-000015 | Mar 10, 2025 | Mar 6, 2025 |
| 8-K | 8-K | 0001140361-25-007862 | Mar 10, 2025 | Mar 6, 2025 |
| SCHEDULE 13D/A | — | 0001072613-25-000223 | Mar 10, 2025 | — |
| S-8 | S-8 | 0001140361-25-007659 | Mar 7, 2025 | — |
| 8-K | 8-K | 0001140361-25-007658 | Mar 7, 2025 | Mar 6, 2025 |
| 8-K | 8-K | 0001854270-25-000008 | Feb 25, 2025 | Feb 23, 2025 |
| SCHEDULE 13G | — | 0001104659-25-014190 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-014202 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-001231 | Feb 14, 2025 | — |
| 4 | FORM 4 | 0001854270-25-000002 | Feb 6, 2025 | Feb 4, 2025 |
| 4 | FORM 4 | 0001854270-25-000004 | Feb 6, 2025 | Feb 4, 2025 |
| 8-K | 8-K | 0001628280-25-004293 | Feb 6, 2025 | Jan 31, 2025 |
| DEF 14A | DEF 14A | 0001140361-25-001942 | Jan 27, 2025 | Mar 6, 2025 |
| PRE 14A | PRE 14A | 0001140361-25-001180 | Jan 15, 2025 | Mar 6, 2025 |
| 8-K | 8-K | 0001140361-25-000337 | Jan 6, 2025 | Dec 31, 2024 |
| D | — | 0001854270-24-000129 | Dec 19, 2024 | — |
| 8-K | 8-K | 0001854270-24-000128 | Dec 16, 2024 | — |
| 4 | PRIMARY DOCUMENT | 0001578563-24-000493 | Dec 11, 2024 | Dec 9, 2024 |
| 4 | FORM 4 | 0001854270-24-000125 | Dec 10, 2024 | Dec 9, 2024 |
| 4 | FORM 4 | 0001854270-24-000123 | Dec 10, 2024 | Dec 9, 2024 |
| 4 | FORM 4 | 0001854270-24-000121 | Dec 10, 2024 | Dec 9, 2024 |
| 3 | FORM 3 | 0001854270-24-000122 | Dec 10, 2024 | Dec 9, 2024 |
| 3 | FORM 3 | 0001854270-24-000124 | Dec 10, 2024 | Dec 9, 2024 |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / SENTI BIOSCIENCES, INC. -- SCHEDULE 13D/A(# | 0001072613-24-000907 | Dec 4, 2024 | — |
| 8-K | 8-K | 0001140361-24-048293 | Dec 3, 2024 | — |
| 144 | — | 0001968582-24-001085 | Dec 2, 2024 | — |
| 8-K | 8-K | 0001140361-24-048114 | Dec 2, 2024 | — |
| 8-K | 8-K | 0001140361-24-048184 | Dec 2, 2024 | Nov 25, 2024 |
| 8-K | 8-K | 0001854270-24-000114 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0001854270-24-000116 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001854270-24-000108 | Oct 25, 2024 | Oct 22, 2024 |
| 8-K | 8-K | 0001854270-24-000105 | Sep 27, 2024 | Sep 23, 2024 |
| 10-Q | 10-Q | 0001854270-24-000101 | Aug 13, 2024 | Jun 30, 2024 |